Frost & Sullivan commends Merck Serono for its excellence in product differentiation
“Merck Serono is lauded for its cutting-edge drug delivery devices - easypod® and cool.click®2 – that facilitate the simple and effective administration of Saizen®, the recombinant HGH used for the treatment of endogenous growth hormone deficiency in children and adults,” noted Frost & Sullivan Healthcare Senior Research Analyst Aiswariya Chidambaram. “These devices successfully address long standing challenges related to poor patient compliance and low adherence to HGH therapy.”
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.